Literature DB >> 23814515

Doing palliative care in the oncology office.

M Jennifer Cheng1, Lauren M King, Erin R Alesi, Thomas J Smith.   

Abstract

Palliative care is cited as providing improved communication, symptom control, treatment knowledge, and survival. The authors feel primary palliative care skills should be part of a physician's armamentarium.

Mesh:

Year:  2013        PMID: 23814515      PMCID: PMC3595443          DOI: 10.1200/JOP.2013.000885

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  44 in total

Review 1.  Octreotide for malignant bowel obstruction: twenty years after.

Authors:  Sebastiano Mercadante; Giampiero Porzio
Journal:  Crit Rev Oncol Hematol       Date:  2012-01-25       Impact factor: 6.312

2.  Hospice care and survival among elderly patients with lung cancer.

Authors:  Akiko M Saito; Mary Beth Landrum; Bridget A Neville; John Z Ayanian; Jane C Weeks; Craig C Earle
Journal:  J Palliat Med       Date:  2011-07-18       Impact factor: 2.947

3.  Integrating palliative care into comprehensive cancer care.

Authors:  Janet L Abrahm
Journal:  J Natl Compr Canc Netw       Date:  2012-10-01       Impact factor: 11.908

4.  Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care.

Authors:  Jennifer S Temel; Joseph A Greer; Sonal Admane; Emily R Gallagher; Vicki A Jackson; Thomas J Lynch; Inga T Lennes; Connie M Dahlin; William F Pirl
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

5.  Michigan oncology practices showed varying adherence rates to practice guidelines, but quality interventions improved care.

Authors:  Douglas W Blayney; Jane Severson; C Jane Martin; Pamela Kadlubek; Thomas Ruane; Kimberley Harrison
Journal:  Health Aff (Millwood)       Date:  2012-04       Impact factor: 6.301

6.  Patients' expectations about effects of chemotherapy for advanced cancer.

Authors:  Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

7.  The health impact of health care on families: a matched cohort study of hospice use by decedents and mortality outcomes in surviving, widowed spouses.

Authors:  Nicholas A Christakis; Theodore J Iwashyna
Journal:  Soc Sci Med       Date:  2003-08       Impact factor: 4.634

8.  Nausea and vomiting in advanced cancer: the Cleveland Clinic protocol.

Authors:  Mona Gupta; Mellar Davis; Susan LeGrand; Declan Walsh; Ruth Lagman
Journal:  J Support Oncol       Date:  2013-03

9.  Comparing hospice and nonhospice patient survival among patients who die within a three-year window.

Authors:  Stephen R Connor; Bruce Pyenson; Kathryn Fitch; Carol Spence; Kosuke Iwasaki
Journal:  J Pain Symptom Manage       Date:  2007-03       Impact factor: 3.612

10.  American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care.

Authors:  Thomas J Smith; Sarah Temin; Erin R Alesi; Amy P Abernethy; Tracy A Balboni; Ethan M Basch; Betty R Ferrell; Matt Loscalzo; Diane E Meier; Judith A Paice; Jeffrey M Peppercorn; Mark Somerfield; Ellen Stovall; Jamie H Von Roenn
Journal:  J Clin Oncol       Date:  2012-02-06       Impact factor: 44.544

View more
  2 in total

1.  Commentary: "the Lake Wobegon effect, a natural human tendency to overestimate one's capabilities" (Wikipedia).

Authors:  Thomas J Smith
Journal:  Milbank Q       Date:  2013-12       Impact factor: 4.911

2.  Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authors:  Gregory A Masters; Sarah Temin; Christopher G Azzoli; Giuseppe Giaccone; Sherman Baker; Julie R Brahmer; Peter M Ellis; Ajeet Gajra; Nancy Rackear; Joan H Schiller; Thomas J Smith; John R Strawn; David Trent; David H Johnson
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.